Artelo Biosciences Inc (ARTL) — Strategic Asset Allocation Index
Artelo Biosciences Inc (ARTL) has a Strategic Asset Allocation Index of 0.2% as of June 2023. Strategic assets (PP&E of $39.00K plus long-term investments of $-) total $39.00K, measured against net assets of $16.27 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Artelo Biosciences Inc (ARTL) asset resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Artelo Biosciences Inc Strategic Asset Allocation Index (2015–2022)
This chart shows how Artelo Biosciences Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2015 to 2022. As of June 2023, the index stands at 0.2%, representing strategic assets of $39.00K against net assets of $16.27 Million USD. See financial flexibility index of Artelo Biosciences Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Artelo Biosciences Inc (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Artelo Biosciences Inc from 2015 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Artelo Biosciences Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | $0.00 | $- | $0.00 | $19.40 Million | ▼ -0.7 pp |
| 2021 | 0.7% | $90.00K | $90.00K | $0.00 | $12.04 Million | ▲ +0.7 pp |
| 2020 | 0.0% | $246.00 | $246.00 | $0.00 | $3.87 Million | ▼ 0.0 pp |
| 2019 | 0.0% | $721.00 | $721.00 | $- | $5.46 Million | ▲ +0.0 pp |
| 2017 | 0.0% | $0.00 | $0.00 | $0.00 | $544.84K | ▲ +0.0 pp |
| 2015 | 0.0% | $0.00 | $0.00 | $0.00 | $15.29K | — |